Clinical Trials Browser

Phase 2 × Simvastatin × Plasma cell × Clear all

NCT01332617 2017-12-29

Phase II Study of Simvastatin for Relapsed/Refractory Myeloma

Phase 2 Withdrawn

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00503763 2015-04-16

PSMMSS

Phase 2 Withdrawn

Smoldering Multiple Myeloma

NCT00399867 2006-12-20

Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.

Phase 2 Completed

Multiple Myeloma